CURRENT WORK
My current work is featured below.
PAST WORK
A small selection of my previous work is featured below.
EDUCATION
Projected Graduation 2025
Indiana University School of Medicine
Doctor of Philosophy
2016
Loyola University
Master of Science: Molecular Biology
2011
University of Mississippi
Bachelor of Science: Biology
GRANTS & AWARDS
2024
Advanced Cyberinfrastructure Student Fellowship - IU Pervasive Technology Institute: January 2024- May 2024
Graduate Student Travel Fellowship - IU School of Medicine Dept of Microbiology and Immunology: May 2024
Poster Award - IU School of Medicine Dept of Microbiology and Immunology Annual Retreat: May 2024
Shrigley/Broxmeyer Graduate Student Research Award - IU School of Medicine Dept of Microbiology and Immunology: October 2024 "In Recognition of Outstanding Scientific Research Accomplishments."
2023
NIH T32 Institutional Training Grantee (NIH T32 5T32AI060519): January 2023- Present
AAI Trainee Abstract Award: May 2023
Poster Award - Wells Center for Pediatric Research Annual Retreat: August 2023
2022
IUPUI Graduate Student Travel Fellowship - For travel to “The Human Microbiome: Ecology and Evolution” Keystone Symposium: December 2022
PUBLICATIONS
Walker, M.T., Bloodworth, J.C., Kountz, T.S., McCarty, S.L., Green, J.E., Ferrie, R.P., Campbell, J.A., Averill, S.H., Beckman, K.B., Grammer, L.C., Eng, C., Avila, P.C., Farber, H.J., Rodriguez-Cintron, W., Rodriguez-Santana, J.R., Serebrisky, D., Thyne, S.M., Seibold, M.A., Burchard, E.G., Kumar, R., Cook-Mills, J.M. (2024) 5-HTP inhibits eosinophilia via intracellular endothelial 5-HTRs; SNPs in 5-HTRs associate with asthmatic lung function. Front Allergy.
Bloodworth, J.C., Hoji, A., Wolff, G., Mandal, R.K., Schmidt, N.W., Deshane, J.S., Morrow, C.D., Kloepfer, K.M., Cook-Mills, J.M. (2023). Dysbiotic lung microbial communities of neonates from allergic mothers confer neonate responsiveness to suboptimal allergen. Front Allergy, Mar 10;4:1135412. doi: 10.3389/falgy.2023.1135412. PMID: 36970065; PMCID: PMC10036811.
Cabanov, A., Flood, B. A., Bloodworth, J. C., Higgs, E. F., Fessler, J., Leung, M. Y. K., Cron, K. R., Trujillo, J., Pyzer, A. R., Rouhani, S., Strohbehn, G., Heiss, B., Ratain, M., Reid, P., Yeo, K. J., Sweis, R. F., Zha, Y., Gajewski, T. F. (2020) Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection. Clinical Cancer Research, (26) (18 Supplement) S04-02; DOI: 10.1158/1557-3265. COVID-19-S04-02
Strohbehn, G. W., Heiss, B. L., Rouhani, S. J., Trujillo, J. A., Yu, J., Kacew, A. J., Higgs, E. F., Bloodworth. J. C., Cabanov, A., Wright, R. C., Koziol, A. K., Weiss, A., Danahey, K., Karrison, T. G., Edens, C. C., Bauer, Ventura, I., Pettit, N. N., Patel, B. K., Pisano, J., Strek, M. E., Gajewski, T. F., Ratain, M. J., Reid, P. D. (2021). COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clinical Pharmacology & Therapeutics, 109 (3):688-696. doi: 10.1002/cpt.2117. Epub 2020 Dec 10. PMID: 33210302; PMCID: PMC7753375.
Sweis, R. F., Golan, S., Barashi, N., Hill, E., Andolfi, C., Werntz, R. P., Bloodworth, J. C., Steinberg, G. D. (2019). Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer. Journal of Clinical Oncology, 37(7_suppl), 423-423. doi:10.1200/jco.2019.37.7_suppl.423
Shah, N., Kumar, S., Zaman, N., Pan, C.C., Bloodworth, J.C., Lei, W., Streicher, J. M., Hempel, N., Mythreye, K., Lee, N. Y. (2018). TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth. Nature Communications, 27;9(1):1696. doi: 10.1038/s41467-018-04121-y.
Higgs, E. F., Flood, B. A., Pyzer, A. R., Rouhani, S.J., Trujillo J. A., Cron, K. R., Cabanov, A., Fessler, J., Bloodworth. J. C., Beavis, K., Yeo, K. J., Sweis, R. F., Zha, Y., Gajewski, T. F. (2020) Abstract PO-067: Tissue banking from patients with SARS-CoV-2 (COVID-19) infection. Clinical Cancer Research, (26) (18 Supplement) PO-067; DOI: 10.1158/1557-3265.COVID-19-PO-067
Pandya, K., Wyatt, D., Gallagher, B., Shah, D., Baker, A., Bloodworth, J. C., Zlobin. A., Pannuti, A., Green. A., Ellis, I.O., Filipovic, A., Sagert, J., Rana. A., Albain, K.S., Miele, L., Denning, M. F., Osipo, C. (2015). PKC Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance. Clinical Cancer Research, 22(1), 175-186. doi:10.1158/1078-0432.ccr-15-0179